Clinical studies recruiting near Fairhope

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart
Phase 3 · CON-10004 Fairhope, AL Investigational Site · Colorado Prevention Center · NCT06024746 Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · Thomas Hospital · NRG Oncology · NCT05624996 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Eastern Shore Research Institute · Amgen · NCT07037433 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · Thomas Hospital · NRG Oncology · NCT05174169 A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not
Phase 3 · FIN-10004 Fairhope, AL Investigational Site · Colorado Prevention Center · NCT06033950 Sacral Neuromodulation for Male Overactive Bladder (MOAB)
NA · Urology Associates · Axonics, Inc. · NCT06511141 Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease o
Phase 3 · Clinical Trial Site · Alnylam Pharmaceuticals · NCT07181109 AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF
Phase 2 · Eastern Shore Research Institute, LLC · Cytokinetics · NCT06793371 A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V60
Phase 2 · Thomas Hospital · SWOG Cancer Research Network · NCT04511013 OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardio
Phase 3 · Eastern Shore Research Institute · Amgen · NCT07136012 Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
Phase 2 · IMC Gulf Coast Gastroenterology, PC · Abivax S.A. · NCT06456593 Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had
Phase 2/Phase 3 · Thomas Hospital · SWOG Cancer Research Network · NCT06616584 Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
Phase 3 · Research Site · AstraZeneca · NCT06307652 Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Phase 2/Phase 3 · Thomas Hospital · SWOG Cancer Research Network · NCT03851445 Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
Phase 2 · Eastern Shore Research Institute · Regeneron Pharmaceuticals · NCT07175428 Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A L
Phase 2 · Thomas Hospital · SWOG Cancer Research Network · NCT05642572 Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After
Phase 3 · Thomas Hospital · Alliance for Clinical Trials in Oncology · NCT05812807 AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM
Phase N/A · Eastern Shore Research Institute · Cordio Medical · NCT06378632 A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopul
Phase 3 · Research Site · AstraZeneca · NCT06283966 MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Phase N/A · Baldwin County Surg Ctr · Stryker Instruments · NCT03072927 A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a
Phase 3 · Research Site · AstraZeneca · NCT07000357 Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
Phase 2/Phase 3 · Gulf Health Hospitals d/b/a Thomas Hospital · DiaMedica Therapeutics Inc · NCT05065216 A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Phase 3 · Eastern Shore Rsrch Inst, LLC · Novo Nordisk A/S · NCT07567001 Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung
Phase 2 · Thomas Hospital · SWOG Cancer Research Network · NCT06031688 A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure P
Phase 3 · Fairhope, AL Investigative Site 10004 · Colorado Prevention Center · NCT06008197 Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Phase 3 · Eastern Shore Research Institute · Amgen · NCT07037459 EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes,
Phase 3 · Eastern Shore Research Group · Boehringer Ingelheim · NCT07064473 Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease
Phase 2/Phase 3 · Nephrology Associates · Vertex Pharmaceuticals Incorporated · NCT05312879 Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
Phase 3 · Research Site · DalCor Pharmaceuticals · NCT05918861 A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Co
Phase 3 · Research Site · AstraZeneca · NCT06742723

Look up another city

Look up another condition